Vimarsana
Biggest News Aggregation in the World

Page 11 - Poster Section News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Poster Section. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Poster Section Today - Breaking & Trending Today

Dxcover Limited: Dxcover to Present New Data on Liquid Biopsy Platform at the 2023 American Association for Cancer Research (AACR) Annual Meeting - Vimarsana News

Dxcover Limited: Dxcover to Present New Data on Liquid Biopsy Platform at the 2023 American Association for Cancer Research (AACR) Annual Meeting

Dxcover Limited, a clinical-stage diagnostics company developing spectroscopic liquid biopsy technology for early detection of multiple cancers, today announced the upcoming presentation of new data

OSE Immunotherapeutics to Present Preclinical and Clinical Research Updates from its Pipeline and Platforms in Immuno-Oncology - Vimarsana News

OSE Immunotherapeutics to Present Preclinical and Clinical Research Updates from its Pipeline and Platforms in Immuno-Oncology

At the 2023 American Association for Cancer Research (AACR) Regulatory News: OSE Immunotherapeutics SA (ISIN: FR0012127173; Mnemo: OSE) (Paris:OSE) today announced it will be presenting five

Sonnet BioTherapeutics, Inc.: Sonnet BioTherapeutics to Present Clinical Data from the SB101 Study with SON-1010 at the AACR 2023 Annual Meeting - Vimarsana News

Sonnet BioTherapeutics, Inc.: Sonnet BioTherapeutics to Present Clinical Data from the SB101 Study with SON-1010 at the AACR 2023 Annual Meeting

PRINCETON, NJ / ACCESSWIRE / March 14, 2023 / Sonnet BioTherapeutics Holdings, Inc. (NASDAQ:SONN) ("Sonnet" or the "Company"), a biopharmaceutical company developing innovative targeted biologic drugs

Kura Oncology Announces Acceptance of Two Abstracts for - Vimarsana News

Kura Oncology Announces Acceptance of Two Abstracts for

– Presentations to highlight preclinical data supporting combination of FTIs with KRASG12C inhibitors and tyrosine kinase inhibitors – SAN DIEGO, March ...

HotSpot Therapeutics to Present Two Poster Presentations on CBL-B Program at AACR Annual Meeting 2023 - Vimarsana News

HotSpot Therapeutics to Present Two Poster Presentations on CBL-B Program at AACR Annual Meeting 2023

/PRNewswire/ -- HotSpot Therapeutics, Inc., a biotechnology company pioneering the discovery and development of oral, small molecule allosteric therapies...